Who is sponsoring NCT00665054?

NCT00665054 is sponsored by Bayer.

What condition does NCT00665054 study?

NCT00665054 studies Erectile Dysfunction.

What drugs are being tested in NCT00665054?

Interventions: Levitra (Vardenafil, BAY38-9456), Placebo.

What is the status of NCT00665054?

NCT00665054 is currently COMPLETED.

Last reviewed 2014-12-23 · How we verify

Multi-centre, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Assess the Efficacy and Tolerability of Vardenafil and Its Influence on Self-esteem and Self Confidence in Subjects With Erectile Dysfunction.

NCT00665054 Phase 4 COMPLETED

Purpose of the study is:- To assess the efficacy and tolerability of vardenafil in male subjects suffering from erectile dysfunction as compared to placebo- To assess the influence of vardenafil on the self-esteem and self-confidence of subjects suffering from erectile dysfunction following treatment with vardenafil as compared to placebo

Details

Lead sponsor	Bayer
Phase	Phase 4
Status	COMPLETED
Enrolment	160
Start date	2004-08
Completion	2005-08

Conditions

Erectile Dysfunction

Interventions

Levitra (Vardenafil, BAY38-9456)
Placebo

Primary outcomes

LOCF improved compared to baseline GAQ results at the end of the study — baseline versus visit 2 visit 5 or premature termination visit

Countries

Turkey (Türkiye)